Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer

Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer

Abstract Background Metastatic relapse of prostate cancer after radiotherapy is a significant cause of prostate cancer-related morbidity and mortality. PLOD2 is a mediator of invasion and metastasis that we identified as being upregulated in our highly aggressive radiorecurrent prostate cancer cell...

Full description

Bibliographic Details
Main Authors: Gavin Frame, Hon Leong, Roni Haas, Xiaoyong Huang, Jessica Wright, Urban Emmenegger, Michelle Downes, Paul C. Boutros, Thomas Kislinger, Stanley K. Liu
Format: Article
Language:English
Published: Nature Portfolio 2024-08-01
Series:BJC Reports
Online Access:https://doi.org/10.1038/s44276-024-00085-3

Internet

https://doi.org/10.1038/s44276-024-00085-3

Similar Items